| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.73e-27 | 35 | 61 | 14 | GO:0015020 |
| GeneOntologyMolecularFunction | retinoic acid binding | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 1.72e-21 | 28 | 61 | 11 | GO:0001972 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 4.77e-19 | 153 | 61 | 15 | GO:0008194 |
| GeneOntologyMolecularFunction | retinoid binding | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 1.73e-18 | 48 | 61 | 11 | GO:0005501 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 ALG8 UGT2B28 HAS2 UGT2B11 | 1.82e-18 | 211 | 61 | 16 | GO:0016758 |
| GeneOntologyMolecularFunction | isoprenoid binding | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 2.22e-18 | 49 | 61 | 11 | GO:0019840 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 ALG8 ST3GAL4 UGT2B28 HAS2 UGT2B11 | 9.57e-18 | 288 | 61 | 17 | GO:0016757 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 4.16e-16 | 107 | 61 | 12 | GO:0033293 |
| GeneOntologyMolecularFunction | carboxylic acid binding | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 6.81e-12 | 239 | 61 | 12 | GO:0031406 |
| GeneOntologyMolecularFunction | organic acid binding | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 1.39e-11 | 254 | 61 | 12 | GO:0043177 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.15e-06 | 398 | 61 | 9 | GO:0046982 |
| GeneOntologyMolecularFunction | palmitoleoyltransferase activity | 9.18e-06 | 2 | 61 | 2 | GO:1990698 | |
| GeneOntologyMolecularFunction | lipid binding | UGT1A4 UGT1A1 UGT1A3 SNX14 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 3.71e-05 | 988 | 61 | 12 | GO:0008289 |
| GeneOntologyMolecularFunction | protein kinase C binding | 4.93e-05 | 66 | 61 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | steroid binding | 5.36e-05 | 133 | 61 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | fatty acid binding | 5.87e-05 | 69 | 61 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.76e-04 | 815 | 61 | 9 | GO:0042803 |
| GeneOntologyMolecularFunction | floppase activity | 1.07e-03 | 16 | 61 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.30e-03 | 28 | 61 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | UGT1A1 ABCA2 PIK3CA UGT1A10 UGT1A8 UGT1A7 TBCK UGT1A9 SGSM3 SIPA1L2 PRDM14 | 3.46e-03 | 1418 | 61 | 11 | GO:0030234 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 8.95e-32 | 21 | 61 | 14 | GO:0052695 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 7.36e-30 | 26 | 61 | 14 | GO:0019585 |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 7.36e-30 | 26 | 61 | 14 | GO:0006063 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | UGT1A1 UGT1A3 UGT1A8 UGT1A7 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.55e-24 | 12 | 61 | 10 | GO:0052697 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.21e-18 | 52 | 61 | 11 | GO:0008210 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 UGT2B28 UGT2B11 | 2.01e-16 | 141 | 61 | 13 | GO:0006805 |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 1.45e-14 | 8 | 61 | 6 | GO:0070980 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 UGT2B28 UGT2B11 | 7.61e-14 | 222 | 61 | 13 | GO:0071466 |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.08e-13 | 10 | 61 | 6 | GO:0018879 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | UGT1A1 UGT1A3 SCN11A ABCA2 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 UGT2B28 CPT1A UGT2B11 | 1.17e-13 | 525 | 61 | 17 | GO:0009410 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.91e-13 | 5 | 61 | 5 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 8.77e-13 | 13 | 61 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.15e-12 | 6 | 61 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.33e-11 | 37 | 61 | 7 | GO:0042537 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 CPT1A ADTRP UGT2B11 | 2.28e-11 | 731 | 61 | 17 | GO:0032787 |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT1A4 UGT1A1 UGT1A3 ABCA2 UGT1A10 UGT1A8 UGT1A7 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 5.95e-11 | 376 | 61 | 13 | GO:0008202 |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.45e-10 | 5 | 61 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 6.80e-10 | 286 | 61 | 11 | GO:0042445 |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.03e-09 | 6 | 61 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.03e-09 | 6 | 61 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.13e-09 | 37 | 61 | 6 | GO:0042178 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 CPT1A ADTRP UGT2B11 | 4.72e-09 | 1035 | 61 | 17 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 CPT1A ADTRP UGT2B11 | 6.55e-09 | 1058 | 61 | 17 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | UGT1A4 UGT1A1 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 CPT1A ADTRP UGT2B11 | 7.13e-09 | 1064 | 61 | 17 | GO:0006082 |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.43e-08 | 10 | 61 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.43e-08 | 10 | 61 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 8.91e-08 | 38 | 61 | 5 | GO:0008209 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.16e-07 | 40 | 61 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 3.46e-07 | 94 | 61 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.99e-07 | 21 | 61 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 CPT1A UGT2B11 | 6.31e-07 | 684 | 61 | 12 | GO:0010817 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.61e-06 | 67 | 61 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | liver development | 2.17e-06 | 202 | 61 | 7 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 2.39e-06 | 205 | 61 | 7 | GO:0061008 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.00e-06 | 34 | 61 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 4.22e-06 | 144 | 61 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.57e-06 | 89 | 61 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.59e-06 | 94 | 61 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 8.60e-06 | 2 | 61 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.47e-05 | 105 | 61 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | UGT1A1 SNX14 ABCA2 ACACB PIK3CA UGT2B4 UGT2B7 UGT2B10 RNF213 UGT2B28 CPT1A ADTRP UGT2B11 | 6.14e-05 | 1253 | 61 | 13 | GO:0044248 |
| GeneOntologyBiologicalProcess | lipid catabolic process | 1.31e-04 | 382 | 61 | 7 | GO:0016042 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid metabolic process | 1.64e-04 | 36 | 61 | 3 | GO:0045939 | |
| GeneOntologyBiologicalProcess | lipid storage | 2.65e-04 | 105 | 61 | 4 | GO:0019915 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 3.06e-04 | 9 | 61 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | lipid modification | 4.26e-04 | 214 | 61 | 5 | GO:0030258 | |
| GeneOntologyBiologicalProcess | eating behavior | 6.10e-04 | 56 | 61 | 3 | GO:0042755 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 6.57e-04 | 13 | 61 | 2 | GO:0006787 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 7.65e-04 | 14 | 61 | 2 | GO:0033015 | |
| GeneOntologyBiologicalProcess | lipid droplet formation | 8.81e-04 | 15 | 61 | 2 | GO:0140042 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 8.96e-04 | 145 | 61 | 4 | GO:0045833 | |
| GeneOntologyBiologicalProcess | gland development | 1.26e-03 | 558 | 61 | 7 | GO:0048732 | |
| GeneOntologyBiologicalProcess | ceramide transport | 1.28e-03 | 18 | 61 | 2 | GO:0035627 | |
| GeneOntologyBiologicalProcess | lipid localization | 1.35e-03 | 565 | 61 | 7 | GO:0010876 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 1.40e-03 | 415 | 61 | 6 | GO:0019216 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CDS2 UGT2B4 UGT2B7 UGT2B10 PORCN UGT1A9 ALG8 SLC28A3 FLRT2 UGT2B28 HAS2 PLD3 UGT2B11 | 3.97e-11 | 1293 | 61 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CDS2 UGT2B4 UGT2B7 UGT2B10 PORCN UGT1A9 ALG8 SLC28A3 FLRT2 UGT2B28 HAS2 PLD3 UGT2B11 | 4.33e-11 | 1299 | 61 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CDS2 UGT2B4 UGT2B7 UGT2B10 PORCN UGT1A9 ALG8 SLC28A3 FLRT2 UGT2B28 HAS2 PLD3 UGT2B11 | 6.44e-11 | 1327 | 61 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.09e-07 | 40 | 61 | 5 | GO:0005640 | |
| GeneOntologyCellularComponent | organelle outer membrane | 1.65e-05 | 279 | 61 | 7 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 1.73e-05 | 281 | 61 | 7 | GO:0019867 | |
| Domain | UDPGT | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.77e-31 | 21 | 60 | 14 | PF00201 |
| Domain | UDPGT | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.77e-31 | 21 | 60 | 14 | PS00375 |
| Domain | UDP_glucos_trans | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.77e-31 | 21 | 60 | 14 | IPR002213 |
| Pathway | REACTOME_GLUCURONIDATION | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 4.02e-29 | 25 | 51 | 14 | M17787 |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 4.02e-29 | 25 | 51 | 14 | M605 |
| Pathway | WP_GLUCURONIDATION | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 8.69e-29 | 26 | 51 | 14 | M39404 |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.59e-28 | 28 | 51 | 14 | M19580 |
| Pathway | REACTOME_GLUCURONIDATION | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 8.34e-27 | 24 | 51 | 13 | MM14599 |
| Pathway | WP_GLUCURONIDATION | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.73e-26 | 25 | 51 | 13 | MM15820 |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | UGT1A4 UGT1A1 UGT1A3 GANC UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 9.98e-26 | 52 | 51 | 15 | M14171 |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.06e-25 | 41 | 51 | 14 | M7399 |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.09e-23 | 51 | 51 | 14 | M17726 |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.65e-23 | 55 | 51 | 14 | M14933 |
| Pathway | REACTOME_ASPIRIN_ADME | UGT1A4 UGT1A1 UGT1A3 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.65e-22 | 44 | 51 | 13 | M45014 |
| Pathway | REACTOME_ASPIRIN_ADME | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.31e-22 | 45 | 51 | 13 | MM15694 |
| Pathway | KEGG_RETINOL_METABOLISM | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.92e-22 | 64 | 51 | 14 | M9488 |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.56e-21 | 70 | 51 | 14 | M16794 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.40e-21 | 72 | 51 | 14 | M9257 |
| Pathway | REACTOME_DRUG_ADME | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 UGT2B28 UGT2B11 | 1.97e-20 | 109 | 51 | 15 | M45012 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.18e-18 | 109 | 51 | 14 | M18788 |
| Pathway | REACTOME_DRUG_ADME | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 UGT2B28 UGT2B11 | 4.23e-18 | 119 | 51 | 14 | MM15692 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 4.91e-17 | 107 | 51 | 13 | MM14595 |
| Pathway | REACTOME_PARACETAMOL_ADME | UGT1A1 UGT1A10 UGT1A8 UGT1A7 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 8.84e-17 | 39 | 51 | 10 | MM15695 |
| Pathway | REACTOME_PREDNISONE_ADME | 7.76e-15 | 23 | 51 | 8 | MM16639 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.78e-14 | 14 | 51 | 7 | M39328 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 2.61e-14 | 220 | 51 | 14 | M10320 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 6.08e-13 | 219 | 51 | 13 | MM14838 |
| Pathway | WP_ESTROGEN_METABOLISM | 8.65e-13 | 22 | 51 | 7 | MM15888 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 UGT2B28 UGT2B11 | 1.63e-12 | 183 | 51 | 12 | M39588 |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 4.19e-09 | 18 | 51 | 5 | M39424 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 6.87e-08 | 153 | 51 | 8 | MM15844 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 5.55e-07 | 45 | 51 | 5 | M39615 | |
| Pathway | REACTOME_HEME_DEGRADATION | 7.05e-07 | 20 | 51 | 4 | MM14721 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 8.35e-07 | 145 | 51 | 7 | M45512 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 8.69e-07 | 21 | 51 | 4 | M39631 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.38e-06 | 29 | 51 | 4 | M45015 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 4.45e-06 | 31 | 51 | 4 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 5.07e-06 | 32 | 51 | 4 | M39567 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 5.07e-06 | 32 | 51 | 4 | MM14719 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 9.59e-06 | 12 | 51 | 3 | M39611 | |
| Pathway | WP_NRF2_PATHWAY | 1.12e-05 | 141 | 51 | 6 | M39454 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.53e-05 | 314 | 51 | 8 | M39428 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.97e-05 | 15 | 51 | 3 | MM15697 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 8.56e-05 | 24 | 51 | 3 | M46445 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.91e-04 | 6 | 51 | 2 | M39437 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 1.91e-04 | 6 | 51 | 2 | M39600 | |
| Pathway | REACTOME_SYNTHESIS_OF_PG | 3.54e-04 | 8 | 51 | 2 | M26961 | |
| Pathway | REACTOME_PREDNISONE_ADME | 5.67e-04 | 10 | 51 | 2 | M46430 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.14e-03 | 14 | 51 | 2 | M46453 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 1.14e-03 | 14 | 51 | 2 | M27098 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 1.14e-03 | 14 | 51 | 2 | MM14788 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.31e-03 | 15 | 51 | 2 | M27060 | |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 1.82e-03 | 67 | 51 | 3 | M39630 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 2.58e-03 | 21 | 51 | 2 | M8601 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 2.58e-03 | 21 | 51 | 2 | MM1463 | |
| Pathway | PID_HEDGEHOG_2PATHWAY | 2.83e-03 | 22 | 51 | 2 | M211 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.83e-03 | 22 | 51 | 2 | M13897 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT2B4 UGT2B7 UGT1A9 | 8.33e-27 | 12 | 61 | 10 | 20308471 |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 8.46e-26 | 9 | 61 | 9 | 22511988 | |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT1A9 | 1.26e-25 | 14 | 61 | 10 | 9295054 | |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 8.45e-25 | 10 | 61 | 9 | 23642732 | |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 8.45e-25 | 10 | 61 | 9 | 11465080 | |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 8.45e-25 | 10 | 61 | 9 | 23371916 | |
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 8.45e-25 | 10 | 61 | 9 | 22558097 |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 UGT2B28 UGT2B11 | 7.19e-24 | 66 | 61 | 13 | 19898482 | |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.85e-23 | 12 | 61 | 9 | 19419973 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.85e-23 | 12 | 61 | 9 | 11434514 |
| Pubmed | 5.55e-23 | 8 | 61 | 8 | 17179145 | ||
| Pubmed | 5.55e-23 | 8 | 61 | 8 | 20610558 | ||
| Pubmed | 5.55e-23 | 8 | 61 | 8 | 18052087 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 6.02e-23 | 13 | 61 | 9 | 22085899 |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 6.02e-23 | 13 | 61 | 9 | 25246029 |
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.68e-22 | 14 | 61 | 9 | 21646302 | |
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.68e-22 | 14 | 61 | 9 | 10836148 |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.68e-22 | 14 | 61 | 9 | 14672974 |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 9.59e-22 | 16 | 61 | 9 | 19414484 |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.03e-21 | 17 | 61 | 9 | 20639394 |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.71e-21 | 19 | 61 | 9 | 23281178 |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.57e-20 | 7 | 61 | 7 | 8467709 | |
| Pubmed | 3.57e-20 | 7 | 61 | 7 | 8464825 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.08e-19 | 24 | 61 | 9 | 24625756 |
| Pubmed | 1.28e-18 | 9 | 61 | 7 | 1339448 | ||
| Pubmed | 2.40e-18 | 18 | 61 | 8 | 20056724 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 2.26e-17 | 6 | 61 | 6 | 19204906 | |
| Pubmed | 2.26e-17 | 6 | 61 | 6 | 20297805 | ||
| Pubmed | 2.81e-17 | 12 | 61 | 7 | 18161889 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 6.31e-16 | 8 | 61 | 6 | 12695355 | |
| Pubmed | 6.31e-16 | 8 | 61 | 6 | 32093886 | ||
| Pubmed | 6.31e-16 | 8 | 61 | 6 | 22579593 | ||
| Pubmed | 6.31e-16 | 8 | 61 | 6 | 10748067 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.14e-16 | 57 | 61 | 9 | 21886157 |
| Pubmed | 1.40e-14 | 5 | 61 | 5 | 15057901 | ||
| Pubmed | 2.94e-13 | 7 | 61 | 5 | 26074487 | ||
| Pubmed | 7.83e-13 | 8 | 61 | 5 | 18719240 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 ST3GAL4 | 3.76e-12 | 211 | 61 | 10 | 24097068 |
| Pubmed | 6.43e-12 | 11 | 61 | 5 | 18695635 | ||
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 1634050 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 8.56e-12 | 4 | 61 | 4 | 18223459 | |
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 1898728 | ||
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 15855726 | ||
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 9535849 | ||
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 8276413 | ||
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 9271343 | ||
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 17558305 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 8.56e-12 | 4 | 61 | 4 | 2108603 | |
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 8280139 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 4.28e-11 | 5 | 61 | 4 | 18597651 | |
| Pubmed | 4.28e-11 | 5 | 61 | 4 | 26010150 | ||
| Pubmed | 4.28e-11 | 5 | 61 | 4 | 20565459 | ||
| Pubmed | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 4.86e-11 | 190 | 61 | 9 | 24816252 | |
| Pubmed | 1.28e-10 | 6 | 61 | 4 | 32527940 | ||
| Pubmed | 2.98e-10 | 7 | 61 | 4 | 27514509 | ||
| Pubmed | 5.96e-10 | 8 | 61 | 4 | 15319294 | ||
| Pubmed | 5.96e-10 | 8 | 61 | 4 | 20142249 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 15247627 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19364970 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 29519853 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 5.13e-09 | 3 | 61 | 3 | 20007669 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19244109 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 11179460 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 28443723 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 26247833 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 8333863 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12051676 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12732365 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 17339869 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 27857056 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 5.13e-09 | 3 | 61 | 3 | 24453052 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 20860988 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19225446 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19712005 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 23789755 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12623074 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 17406868 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19996319 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 36571650 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19303655 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 16397224 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12847094 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 22367021 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 5.13e-09 | 3 | 61 | 3 | 16969497 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 15472229 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 23611809 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 24255116 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 18946804 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 17440429 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 20147615 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 10024527 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 20628391 | ||
| Pubmed | Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. | 2.05e-08 | 4 | 61 | 3 | 15486048 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 16849011 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 23700788 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 15318931 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 7677729 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 4.28e-07 | 9 | 61 | 3 | 20732626 | |
| Pubmed | 6.04e-07 | 38 | 61 | 4 | 20214802 | ||
| Interaction | UGT2B28 interactions | 4.74e-07 | 6 | 59 | 3 | int:UGT2B28 | |
| Interaction | UGT1A9 interactions | 6.68e-06 | 13 | 59 | 3 | int:UGT1A9 | |
| Interaction | CYP3A4 interactions | 1.57e-05 | 17 | 59 | 3 | int:CYP3A4 | |
| Interaction | UGT1A7 interactions | 2.33e-05 | 57 | 59 | 4 | int:UGT1A7 | |
| Interaction | UGT1A8 interactions | 2.52e-05 | 3 | 59 | 2 | int:UGT1A8 | |
| Interaction | UGT1A3 interactions | 8.38e-05 | 5 | 59 | 2 | int:UGT1A3 | |
| Interaction | UGT2B10 interactions | 8.38e-05 | 5 | 59 | 2 | int:UGT2B10 | |
| Interaction | UGT1A10 interactions | 1.22e-04 | 33 | 59 | 3 | int:UGT1A10 | |
| Interaction | UGT2B11 interactions | 1.75e-04 | 7 | 59 | 2 | int:UGT2B11 | |
| Cytoband | 2q37 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.37e-19 | 31 | 61 | 9 | 2q37 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.01e-11 | 226 | 61 | 9 | chr2q37 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.24e-06 | 157 | 61 | 5 | chr4q13 | |
| Cytoband | 4q13.2 | 9.77e-06 | 31 | 61 | 3 | 4q13.2 | |
| Cytoband | 4q13 | 1.80e-04 | 15 | 61 | 2 | 4q13 | |
| GeneFamily | UDP glucuronosyltransferases | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.43e-29 | 32 | 47 | 14 | 363 |
| GeneFamily | ATP binding cassette subfamily A | 5.90e-04 | 14 | 47 | 2 | 805 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 1.40e-07 | 53 | 60 | 5 | MM1203 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 3.49e-07 | 121 | 60 | 6 | MM935 | |
| Coexpression | NFE2L2.V2 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.15e-06 | 469 | 60 | 9 | M2870 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR | 1.44e-06 | 154 | 60 | 6 | MM1313 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 3.91e-06 | 103 | 60 | 5 | MM919 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 1.03e-05 | 330 | 60 | 7 | MM1120 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 7.51e-05 | 190 | 60 | 5 | MM1311 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 9.78e-05 | 201 | 60 | 5 | MM1294 | |
| CoexpressionAtlas | liver | 1.98e-05 | 419 | 59 | 8 | liver | |
| ToppCell | mLN-(0)_NK_cell-(00)_NK|mLN / shred on region, Cell_type, and subtype | 7.83e-06 | 199 | 61 | 5 | 59d8e4f57580c7273308c32e5308fc1d704b1f6d | |
| ToppCell | mLN-NK_cell-NK|mLN / Region, Cell class and subclass | 7.83e-06 | 199 | 61 | 5 | cc9836b8d18edabe8849a3e948b84d954ef68c48 | |
| ToppCell | mLN-(0)_NK_cell|mLN / shred on region, Cell_type, and subtype | 7.83e-06 | 199 | 61 | 5 | 05f5ae4c049f242131a7f59bcce4b18ed52f11be | |
| ToppCell | mLN-NK_cell|mLN / Region, Cell class and subclass | 7.83e-06 | 199 | 61 | 5 | dcc1d9a3f6f0e64f111d18386bfe5b154e9d5bbe | |
| Computational | Genes in the cancer module 227. | 1.28e-05 | 15 | 34 | 3 | MODULE_227 | |
| Computational | Steroid hormone and heme metabolism. | 1.57e-05 | 16 | 34 | 3 | MODULE_505 | |
| Drug | C1 11-32 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 4.58e-34 | 18 | 60 | 14 | CID000443077 |
| Drug | C11131 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 4.58e-34 | 18 | 60 | 14 | CID000443076 |
| Drug | estriol-16-glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.73e-32 | 21 | 60 | 14 | CID000122281 |
| Drug | 7-hydroxycoumarin glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.31e-32 | 29 | 60 | 15 | CID000125641 |
| Drug | estradiol-3-glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.21e-31 | 23 | 60 | 14 | CID000066651 |
| Drug | BP-3,6-quinol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.06e-31 | 33 | 60 | 15 | CID000119292 |
| Drug | AC1NOWCJ | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 9.55e-31 | 35 | 60 | 15 | CID005120112 |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 9.55e-31 | 35 | 60 | 15 | CID010436171 |
| Drug | l-borneol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.74e-30 | 37 | 60 | 15 | CID000010049 |
| Drug | AC1NQGK1 | UGT1A4 UGT1A1 UGT1A3 GANC UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 5.86e-30 | 52 | 60 | 16 | CID005195977 |
| Drug | harmol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.17e-29 | 40 | 60 | 15 | CID000068094 |
| Drug | androsterone glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 4.39e-29 | 43 | 60 | 15 | CID000114833 |
| Drug | 7,8-benzoquinoline | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 4.39e-29 | 43 | 60 | 15 | CID000009191 |
| Drug | 4-hydroxybiphenyl | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 PORCN UGT1A9 UGT2B28 HAS2 UGT2B11 | 6.12e-29 | 59 | 60 | 16 | CID000007103 |
| Drug | MS-222 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 6.65e-29 | 44 | 60 | 15 | CID000011400 |
| Drug | AC1Q6OQG | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.19e-28 | 33 | 60 | 14 | CID000009686 |
| Drug | salicylamide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.14e-28 | 48 | 60 | 15 | CID000005147 |
| Drug | estrone-3-glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 3.37e-28 | 35 | 60 | 14 | CID000115255 |
| Drug | cotinine-N-glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT2B10 UGT1A9 | 1.25e-27 | 13 | 60 | 11 | CID000000411 |
| Drug | testosterone glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 5.05e-27 | 41 | 60 | 14 | CID000108192 |
| Drug | propranolol glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 5.82e-27 | 14 | 60 | 11 | CID000119515 |
| Drug | phenolphthalein | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 8.38e-27 | 58 | 60 | 15 | CID000004764 |
| Drug | 4-hydroxyestrone | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.12e-26 | 59 | 60 | 15 | CID000018418 |
| Drug | acetaminophen glucuronide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.12e-26 | 59 | 60 | 15 | CID000083944 |
| Drug | SN-38G | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.12e-26 | 59 | 60 | 15 | CID000443154 |
| Drug | UDP-alpha-d-xylopyranose | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.49e-26 | 60 | 60 | 15 | CID000001165 |
| Drug | 3-OHBaP | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.41e-26 | 63 | 60 | 15 | CID000025890 |
| Drug | 4-nitrophenyl)imidazole | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 8.04e-26 | 11 | 60 | 10 | CID000123155 |
| Drug | Meldola | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.23e-25 | 68 | 60 | 15 | CID000081507 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 1.97e-25 | 17 | 60 | 11 | CID000003573 |
| Drug | eugenol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.98e-25 | 73 | 60 | 15 | CID000003314 |
| Drug | N-OH-DABZ | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 4.81e-25 | 12 | 60 | 10 | CID000051366 |
| Drug | 7-hydroxycoumarin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 6.22e-25 | 75 | 60 | 15 | CID005281426 |
| Drug | AC1N8H7N | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.19e-24 | 78 | 60 | 15 | CID004318740 |
| Drug | benzyloxyresorufin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.19e-24 | 78 | 60 | 15 | CID000114982 |
| Drug | urochloralic acid | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.84e-24 | 59 | 60 | 14 | CID003036914 |
| Drug | acridine | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.20e-24 | 81 | 60 | 15 | CID000009215 |
| Drug | AC1L1OBF | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 2.65e-24 | 20 | 60 | 11 | CID000032736 |
| Drug | AC1MRQNQ | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.27e-24 | 9 | 60 | 9 | CID003522271 |
| Drug | DHPASiU | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.27e-24 | 9 | 60 | 9 | CID000197602 |
| Drug | Chebi:32663 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.27e-24 | 9 | 60 | 9 | CID005460873 |
| Drug | 3-iodophenol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.27e-24 | 9 | 60 | 9 | CID000012272 |
| Drug | AC1L4J7U | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.27e-24 | 9 | 60 | 9 | CID000186631 |
| Drug | 5 alpha-androstane | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.98e-24 | 84 | 60 | 15 | CID000094144 |
| Drug | 7-ethoxycoumarin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 5.83e-24 | 86 | 60 | 15 | CID000035703 |
| Drug | menthol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 7.03e-24 | 87 | 60 | 15 | CID000001254 |
| Drug | pentoxyresorufin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 7.03e-24 | 87 | 60 | 15 | CID000107683 |
| Drug | NNAL | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 | 7.52e-24 | 32 | 60 | 12 | CID000104856 |
| Drug | fibrates | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 CPT1A UGT2B11 | 1.17e-23 | 118 | 60 | 16 | CID000002797 |
| Drug | 4-aminobiphenyl | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.73e-23 | 92 | 60 | 15 | CID000007102 |
| Drug | p-nitroanisole | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.73e-23 | 92 | 60 | 15 | CID000007485 |
| Drug | 2-naphthol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.06e-23 | 93 | 60 | 15 | CID000008663 |
| Drug | coumarin-3-carboxylic acid | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 2.18e-23 | 15 | 60 | 10 | CID000010752 |
| Drug | DCNB | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.90e-23 | 95 | 60 | 15 | CID000007443 |
| Drug | ethoxyresorufin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.90e-23 | 95 | 60 | 15 | CID000003294 |
| Drug | AS-3201 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 3.91e-23 | 24 | 60 | 11 | CID000153948 |
| Drug | DB04103 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 4.05e-23 | 97 | 60 | 15 | CID004469987 |
| Drug | 1-naphthol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 4.78e-23 | 98 | 60 | 15 | CID000007005 |
| Drug | 2,2,2-trichloroethanol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 4.99e-23 | 73 | 60 | 14 | CID000008259 |
| Drug | 1'-hydroxyestragole | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 5.79e-23 | 16 | 60 | 10 | CID000040003 |
| Drug | N-acetylbenzidine | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 6.98e-23 | 25 | 60 | 11 | CID000018787 |
| Drug | 3-hydroxyandrostan-17-one | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 9.05e-23 | 102 | 60 | 15 | CID000000225 |
| Drug | 16-epiestriol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 UGT2B11 | 1.13e-22 | 77 | 60 | 14 | CID000003269 |
| Drug | chrysin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.67e-22 | 106 | 60 | 15 | CID005281607 |
| Drug | AC1O5XMV | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.79e-22 | 11 | 60 | 9 | CID006442661 |
| Drug | 4-nitrophenol | UGT1A4 UGT1A1 UGT1A3 GANC UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 PORCN UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.83e-22 | 177 | 60 | 17 | CID000000980 |
| Drug | fluconazole | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.94e-22 | 107 | 60 | 15 | CID000003365 |
| Drug | diflunisal | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 2.03e-22 | 27 | 60 | 11 | CID000003059 |
| Drug | 2-naphthylamine | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.01e-22 | 110 | 60 | 15 | CID000007057 |
| Drug | ethyl-beta-D-6-glucosiduronic acid | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 3.15e-22 | 18 | 60 | 10 | CID000152226 |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 3.15e-22 | 18 | 60 | 10 | CID000036614 |
| Drug | ApApG | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 3.15e-22 | 18 | 60 | 10 | CID003081975 |
| Drug | SN-38 | UGT1A4 UGT1A1 UGT1A3 ABCA2 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 ST3GAL4 UGT2B28 HAS2 UGT2B11 | 3.61e-22 | 184 | 60 | 17 | CID000104842 |
| Drug | PTBP | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 | 3.61e-22 | 42 | 60 | 12 | CID000007393 |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 5.37e-22 | 29 | 60 | 11 | CID005375667 |
| Drug | trans-3'-hydroxycotinine | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 5.37e-22 | 29 | 60 | 11 | CID000000414 |
| Drug | almokalant | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B7 UGT1A9 | 6.64e-22 | 19 | 60 | 10 | CID003033962 |
| Drug | lithocholic acid | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 6.96e-22 | 116 | 60 | 15 | CID000009903 |
| Drug | ethoxyquin | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 6.96e-22 | 116 | 60 | 15 | CID000003293 |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.15e-22 | 12 | 60 | 9 | CID000088735 |
| Drug | 2,4,6-TCB | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.15e-22 | 12 | 60 | 9 | CID000037247 |
| Drug | 7,7,7-triphenylheptanoic acid | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.15e-22 | 12 | 60 | 9 | CID000276709 |
| Drug | nonanoyl-N-methylglucamide | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 7.15e-22 | 12 | 60 | 9 | CID000160090 |
| Drug | AC1Q7AUJ | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 7.97e-22 | 117 | 60 | 15 | CID000003303 |
| Drug | tolcapone | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 8.47e-22 | 30 | 60 | 11 | CID004659569 |
| Drug | alpha-naphthoflavone | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 9.11e-22 | 118 | 60 | 15 | CID000011790 |
| Drug | benzphetamine | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.04e-21 | 119 | 60 | 15 | CID000002341 |
| Drug | tritanol | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.32e-21 | 13 | 60 | 9 | CID000006457 |
| Drug | 5-azido-UDP-glucuronic acid | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.32e-21 | 13 | 60 | 9 | CID003081279 |
| Drug | hexobarbital | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 2.89e-21 | 127 | 60 | 15 | CID000003608 |
| Drug | R(-)-Denopamine | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 | 2.98e-21 | 33 | 60 | 11 | CID000003818 |
| Drug | AC1L1FK5 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 3.69e-21 | 129 | 60 | 15 | CID000003272 |
| Drug | PCB-61 | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 6.48e-21 | 14 | 60 | 9 | CID000036401 |
| Drug | oltipraz | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 9.44e-21 | 137 | 60 | 15 | CID000047318 |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.62e-20 | 15 | 60 | 9 | CID000040469 |
| Drug | sulforaphane nitrile | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.62e-20 | 15 | 60 | 9 | CID000543743 |
| Drug | afloqualone | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.62e-20 | 15 | 60 | 9 | CID000002040 |
| Drug | naphthyl sulphate | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.62e-20 | 15 | 60 | 9 | CID000114775 |
| Drug | aniline | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.65e-20 | 142 | 60 | 15 | CID000006115 |
| Drug | butylated hydroxytoluene | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B28 HAS2 UGT2B11 | 1.84e-20 | 143 | 60 | 15 | CID000031404 |
| Disease | X-11442 measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.69e-25 | 9 | 59 | 9 | EFO_0021236 |
| Disease | X-11441 measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.69e-25 | 9 | 59 | 9 | EFO_0021235 |
| Disease | circulating cell free DNA measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.69e-25 | 9 | 59 | 9 | EFO_0004739 |
| Disease | bilirubin measurement, response to xenobiotic stimulus | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.69e-25 | 9 | 59 | 9 | EFO_0004570, GO_0009410 |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.69e-24 | 10 | 59 | 9 | EFO_0802185 |
| Disease | bilirubin measurement, response to tenofovir | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.69e-24 | 10 | 59 | 9 | EFO_0004570, EFO_0009279 |
| Disease | X-21796 measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.48e-23 | 11 | 59 | 9 | EFO_0800825 |
| Disease | insomnia, bilirubin measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.48e-23 | 11 | 59 | 9 | EFO_0004570, EFO_0004698 |
| Disease | histidine betaine (hercynine) measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.48e-23 | 11 | 59 | 9 | EFO_0800972 |
| Disease | aldosterone measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.48e-23 | 11 | 59 | 9 | EFO_0010219 |
| Disease | biliverdin measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 5.90e-23 | 12 | 59 | 9 | EFO_0021033 |
| Disease | X-11793--oxidized bilirubin measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.56e-22 | 8 | 59 | 8 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.40e-21 | 9 | 59 | 8 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.40e-21 | 9 | 59 | 8 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.40e-21 | 9 | 59 | 8 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.40e-21 | 9 | 59 | 8 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.40e-21 | 9 | 59 | 8 | EFO_0020691 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 6.47e-21 | 17 | 59 | 9 | EFO_0004611, EFO_0007800 |
| Disease | X-21448 measurement | 6.99e-21 | 10 | 59 | 8 | EFO_0800816 | |
| Disease | X-23974 measurement | 6.99e-21 | 10 | 59 | 8 | EFO_0800867 | |
| Disease | plasma N-desmethylclozapine measurement | 2.56e-20 | 11 | 59 | 8 | EFO_0600039 | |
| Disease | p-cresol glucuronide measurement | 7.66e-20 | 12 | 59 | 8 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.99e-19 | 13 | 59 | 8 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 1.99e-19 | 13 | 59 | 8 | EFO_0800587 | |
| Disease | serum N-desmethylclozapine measurement | 7.06e-19 | 8 | 59 | 7 | EFO_0600043 | |
| Disease | xanthurenate measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.62e-18 | 29 | 59 | 9 | EFO_0010551 |
| Disease | response to dolutegravir | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 3.73e-18 | 30 | 59 | 9 | EFO_0600017 |
| Disease | angiopoietin-related protein 1 measurement | 6.71e-18 | 18 | 59 | 8 | EFO_0801382 | |
| Disease | pregnenetriol sulfate measurement | 2.90e-17 | 11 | 59 | 7 | EFO_0800586 | |
| Disease | tissue factor measurement | 3.11e-17 | 21 | 59 | 8 | EFO_0010623 | |
| Disease | vitamin D deficiency | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT1A9 UGT2B11 | 3.21e-17 | 37 | 59 | 9 | EFO_0003762 |
| Disease | plasma clozapine measurement | 1.37e-15 | 8 | 59 | 6 | EFO_0600038 | |
| Disease | X-21441 measurement | 1.69e-15 | 17 | 59 | 7 | EFO_0800814 | |
| Disease | urate measurement, spine bone mineral density | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 2.66e-15 | 58 | 59 | 9 | EFO_0004531, EFO_0007701 |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 2.69e-14 | 5 | 59 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 2.69e-14 | 5 | 59 | 5 | EFO_0801853 | |
| Disease | vitamin D measurement, COVID-19 | 6.59e-14 | 49 | 59 | 8 | EFO_0004631, MONDO_0100096 | |
| Disease | cholelithiasis | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 1.36e-13 | 88 | 59 | 9 | EFO_0004799 |
| Disease | X-21339 measurement | 5.62e-13 | 7 | 59 | 5 | EFO_0800808 | |
| Disease | gallstones | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 | 9.05e-13 | 108 | 59 | 9 | EFO_0004210 |
| Disease | vitamin D measurement | UGT1A4 ZNF680 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B11 | 2.71e-12 | 336 | 59 | 12 | EFO_0004631 |
| Disease | thyroxine measurement | 5.47e-12 | 83 | 59 | 8 | EFO_0005130 | |
| Disease | hormone measurement | 6.04e-12 | 84 | 59 | 8 | EFO_0004730 | |
| Disease | metabolite measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 UGT2B11 | 6.58e-11 | 560 | 59 | 13 | EFO_0004725 |
| Disease | 5-hydroxyindole sulfate measurement | 7.20e-11 | 5 | 59 | 4 | EFO_0800085 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.80e-09 | 9 | 59 | 4 | EFO_0600040 | |
| Disease | neuroblastoma, cutaneous melanoma | 2.55e-09 | 28 | 59 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | blood 4-oxo-retinoic acid measurement | 7.59e-09 | 3 | 59 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 7.59e-09 | 3 | 59 | 3 | EFO_0800043 | |
| Disease | bilirubin measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B10 UGT1A9 | 1.68e-08 | 442 | 59 | 10 | EFO_0004570 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.81e-08 | 147 | 59 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | apolipoprotein B measurement | UGT1A4 UGT1A3 ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 ST3GAL4 ADTRP | 7.14e-08 | 663 | 59 | 11 | EFO_0004615 |
| Disease | non-high density lipoprotein cholesterol measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 ST3GAL4 ADTRP | 1.48e-07 | 713 | 59 | 11 | EFO_0005689 |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.51e-07 | 6 | 59 | 3 | EFO_0800566 | |
| Disease | indoleacetate measurement | 9.02e-07 | 10 | 59 | 3 | EFO_0021015 | |
| Disease | serum gamma-glutamyl transferase measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 ST3GAL4 SIPA1L2 | 1.71e-06 | 914 | 59 | 11 | EFO_0004532 |
| Disease | X-24588 measurement | 2.14e-06 | 13 | 59 | 3 | EFO_0800898 | |
| Disease | X-19141 measurement | 2.14e-06 | 13 | 59 | 3 | EFO_0800799 | |
| Disease | serum metabolite measurement | UGT1A4 UGT1A1 UGT1A3 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 SLC28A3 CPT1A | 2.35e-06 | 945 | 59 | 11 | EFO_0005653 |
| Disease | phosphatidylcholine 36:4 measurement | 6.07e-06 | 18 | 59 | 3 | EFO_0010382 | |
| Disease | testosterone measurement | UGT1A4 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT2B4 UGT2B7 UGT2B10 UGT1A9 SLC28A3 UGT2B11 | 6.85e-06 | 1275 | 59 | 12 | EFO_0004908 |
| Disease | free androgen index | 9.62e-06 | 374 | 59 | 7 | EFO_0007005 | |
| Disease | X-24947 measurement | 1.14e-05 | 22 | 59 | 3 | EFO_0800910 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (is_implicated_in) | 2.35e-05 | 4 | 59 | 2 | DOID:0050997 (is_implicated_in) | |
| Disease | Dysequilibrium syndrome | 3.92e-05 | 5 | 59 | 2 | C0394006 | |
| Disease | lipid metabolism disorder (is_implicated_in) | 5.87e-05 | 6 | 59 | 2 | DOID:3146 (is_implicated_in) | |
| Disease | vanillylmandelate (VMA) measurement | 8.20e-05 | 7 | 59 | 2 | EFO_0800119 | |
| Disease | deoxycholic acid glucuronide measurement | 1.09e-04 | 8 | 59 | 2 | EFO_0800575 | |
| Disease | urate measurement, bone density | 2.29e-04 | 619 | 59 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | disease progression measurement | 2.52e-04 | 61 | 59 | 3 | EFO_0008336 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 2.56e-04 | 12 | 59 | 2 | DOID:0050997 (implicated_via_orthology) | |
| Disease | dodecanedioate measurement | 2.56e-04 | 12 | 59 | 2 | EFO_0021054 | |
| Disease | Lung cancer | 3.52e-04 | 14 | 59 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 3.52e-04 | 14 | 59 | 2 | 211980 | |
| Disease | Neoplasm of lung | 3.52e-04 | 14 | 59 | 2 | cv:C0024121 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.44e-03 | 28 | 59 | 2 | C1368275 | |
| Disease | urinary metabolite measurement | 1.48e-03 | 245 | 59 | 4 | EFO_0005116 | |
| Disease | Carcinoma, Basal Cell | 1.54e-03 | 29 | 59 | 2 | C4721806 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FWVEFVMRHKGAPHL | 461 | P35503 | |
| LWLKFHRHQTEMIIT | 276 | O95936 | |
| LHNTFLELWTMVHFL | 1251 | Q96L91 | |
| HHTWLIFVFLVEMGK | 731 | Q8NEM8 | |
| VIPVWLNHAMHTFIF | 121 | Q96IZ2 | |
| SHLVIHNLFEGMIWF | 211 | O95674 | |
| AIHWAAYMGHIEVVK | 176 | O15084 | |
| LKVLLSYHGWMFTEH | 126 | P50416 | |
| MGVHPVIHFLAWFLE | 3606 | Q86UQ4 | |
| RMEAHAKFAVLWHLT | 926 | Q5JWR5 | |
| VVLLSVFCWHMHKKG | 556 | O43155 | |
| HSLILFWFPMKALEH | 971 | Q9NTI2 | |
| GMAEEIKHMFHVAWV | 1836 | O00763 | |
| DMQKLTHGVLHTKFW | 191 | Q8IV08 | |
| IFVHGDLKWDIFQVM | 4546 | Q2LD37 | |
| WTIFHAMRHPIIFFS | 306 | Q13585 | |
| IWVTKHVLKGLDFLH | 231 | P41279 | |
| HVHWMSESGIIDVFL | 321 | Q8TET4 | |
| IWVIGFFHALLHSVM | 146 | P58182 | |
| QRIGHFFFWHLKSEM | 661 | P42336 | |
| QPKMLAIFWFHAHEI | 81 | Q8NGF1 | |
| HFFQLHMVWVVLLSL | 66 | Q9H237 | |
| LEEVHIHSTMIGKIW | 11 | P57773 | |
| VNFKAFPMELHLIHW | 131 | P35219 | |
| KHHLWMTYEAIITGF | 371 | Q92819 | |
| VLMHSHVVIIWLFLA | 776 | Q9BZC7 | |
| ASHKAVLHGKFMWVI | 306 | Q5VV63 | |
| VEIWLNHVLGHMKAT | 1676 | Q9NYC9 | |
| VMWEIFEDGHLSHFI | 301 | Q9GZV8 | |
| VFAVSWMPLHLFHVV | 376 | Q15761 | |
| FSHKFMHWQEELLLG | 286 | Q9Y6C5 | |
| EGVRDMLVKHHLFSW | 731 | Q96HU1 | |
| DAHLFSIGAIMWHVI | 846 | Q9P2F8 | |
| LLVLVAFKAMDFHWI | 186 | Q11206 | |
| FVVWDHLMAKYEHRI | 141 | Q9HAS3 | |
| ICMVFEVLGHHLLKW | 161 | Q96SB4 | |
| VHFHVMRLTDSLFLW | 26 | Q5JS54 | |
| LSSFMFGWHVHEKAI | 371 | Q9BVK2 | |
| KVFRWFHEHSAMLLA | 2646 | Q63HN8 | |
| FGFIENLMWHKLVHQ | 706 | P0CJ78 | |
| DHDVWKLNVAHVLFM | 456 | Q8N4P2 | |
| VFWVEFVMRHKGAPH | 456 | Q9HAW8 | |
| DWLHHLLMGTRILFK | 806 | Q9Y5W7 | |
| HFWIVFVMPRAKGHI | 176 | Q7RTY8 | |
| VFWIEFVMRHKGAKH | 461 | P06133 | |
| DLAVFWVEFVMRHKG | 456 | P22309 | |
| FWVEFVMRHKGAPHL | 461 | P35504 | |
| WFLTMFTHVFPLHKI | 626 | Q8TEA7 | |
| VFWVEFVMRHKGAPH | 456 | O60656 | |
| VFWIEFVMPHKGAKH | 461 | O75310 | |
| DHDVWKLNVAHVLFM | 456 | Q86WT1 | |
| FWIEFVMRHKGAKHL | 461 | P36537 | |
| RFHWIHTPLVLTGKM | 71 | Q8N3G9 | |
| IFTHIFILEMVLKWV | 1096 | Q9UI33 | |
| YWVLSFTKHMIIHRG | 166 | Q9NSJ1 | |
| LAVFWVEFVMRHKGA | 456 | P19224 | |
| VFWIEFVMCHKGAKH | 461 | Q9BY64 | |
| VFWIEFVMRHKGAKH | 461 | P16662 | |
| WFSELIKHKGIHMGE | 221 | Q8NEM1 | |
| VFWVEFVMRHKGAPH | 456 | Q9HAW7 | |
| TAHWHKGTTLMIKFE | 161 | Q8IUR0 | |
| VFWVEFVMRHKGAPH | 456 | Q9HAW9 | |
| FWVEFVMRHKGAPHL | 461 | P22310 | |
| SFVKLEHWLETLRMH | 596 | P53667 |